Market Research Industry Reports

Antares Pharma Inc (ATRS) - Product Pipeline Analysis, 2018 Update

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes self-administered parenteral pharmaceuticals and drug delivery systems and technologies. The companys portfolio encompasses novel therapeutic products for the treatment of polyarticular juvenile idiopathic arthritis, and adults with severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache, and to reduce the risk of preterm birth in pregnant women. It caters its subcutaneous injection technology platforms to both generic and branded injectables. Antares Pharmas injectables are available in disposable multi-dose pen injectors and unit dose containers. The company employs its drug delivery systems to advance drug compounds and drug delivery methods. It also advances various product development programs in partnership with various leading pharmaceutical companies including Teva and AMAG. The company has a presence in the US and Switzerland. Antares Pharma is headquartered in Ewing, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Antares Pharma Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

2
List of Tables 3
List of Figures 3
Antares Pharma Inc Company Overview 4
Antares Pharma Inc Company Snapshot 4
Antares Pharma Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Antares Pharma Inc Pipeline Analysis Overview 6
Business Description 6
Antares Pharma Inc - Key Facts 6
Antares Pharma Inc - Major Products and Services 7
Antares Pharma Inc Pipeline Products by Development Stage 8
Antares Pharma Inc Pipeline Products Overview 10
Teva Pen 1 10
Teva Pen 1 Product Overview 10
Vibex EPI 11
Vibex EPI Product Overview 11
Vibex QS M 12
Vibex QS M Product Overview 12
Antares Pharma Inc - Key Competitors 13
Antares Pharma Inc - Key Employees 14
Antares Pharma Inc - Key Employee Biographies 15
Antares Pharma Inc - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Antares Pharma Inc, Recent Developments 17
May 30, 2018: Antares Pharma Announces Receipt of Third Installment From Sale of ZOMAJET Needle-Free Delivery System 17
May 08, 2018: Antares Pharma Reports First Quarter 2018 Operating and Financial Results 17
Mar 27, 2018: Antares Pharma Provides XYOSTED Regulatory Update 18
Mar 01, 2018: Antares Pharma Announces Receipt of Second Installment from Sale of Zomajet Needle-Free Delivery System 18
Feb 14, 2018: Antares Pharma Announces FDA Approval of Partners Product Utilizing Our QuickShot Auto Injector 18
Jan 31, 2018: Ferrings ZOMACTON (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Deficiency in Adults 19
Jan 16, 2018: Antares Pharma Provides XYOSTED Regulatory Update 20
Nov 07, 2017: Antares Pharma Reports Third Quarter 2017 Operating and Financial Results 20
Oct 12, 2017: Antares Pharma Provides Xyosted Regulatory Update 21
Aug 08, 2017: Antares Pharma Reports Second Quarter 2017 Operating And Financial Results 21
Appendix 24
Methodology 24
About GlobalData 26
Contact Us 26
Disclaimer 27

List Of Tables

List of Tables
Antares Pharma Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Antares Pharma Inc Pipeline Products by Equipment Type 5
Antares Pharma Inc Pipeline Products by Indication 5
Antares Pharma Inc, Key Facts 6
Antares Pharma Inc, Major Products and Services 7
Antares Pharma Inc Number of Pipeline Products by Development Stage 8
Antares Pharma Inc Pipeline Products Summary by Development Stage 9
Teva Pen 1 - Product Status 10
Teva Pen 1 - Product Description 10
Vibex EPI - Product Status 11
Vibex EPI - Product Description 11
Vibex QS M - Product Status 12
Vibex QS M - Product Description 12
Antares Pharma Inc, Key Employees 14
Antares Pharma Inc, Key Employee Biographies 15
Antares Pharma Inc, Other Locations 16
Antares Pharma Inc, Subsidiaries 16
Glossary 25

List Of Figures

List of Figures
Antares Pharma Inc Pipeline Products by Equipment Type 5
Antares Pharma Inc Pipeline Products by Development Stage 8

Antares Pharma Inc (ATRS) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes self-administered parenteral pharmaceuticals and drug delivery systems and technologies. The companys portfolio encompasses novel

USD 250View Report

Antares Pharma Inc (ATRS) - Product Pipeline Analysis, 2018 Update

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes self-administered parenteral pharmaceuticals and drug delivery systems and technologies. The companys portfolio encompasses novel

USD 750View Report

Astellas Pharma Inc. - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Astellas Pharma Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Astellas Pharma Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350View Report

MEI Pharma Inc (MEIP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

MEI Pharma Inc (MEI), formerly Marshall Edwards Inc is an oncology company that focuses on the development of drugs for the treatment of cancer. The companys drug candidates include pracinostat,

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 750
  • Site Licence    USD 1500
  • Enterprise Wide Licence    USD 2250
$ 750

Reports Details

Published Date : Jun 2018
No. of Pages :27
Country :United States of America
Category :Medical Devices
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube